CIK 0001756262 · Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- Phone
- 9785520900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-20 | TOBIN JAMES R Director | Grant or award | +2,922 | 6,981 | ||
| 2026-05-20 | Kania Edwin Director | Grant or award | +2,922 | 263,732 | ||
| 2026-05-19 | Forsyth Matthew S. See Remarks | Grant or award | +15,409 | 15,409 | ||
| 2026-05-19 | Forsyth Matthew S. See Remarks | Grant or award · Stock Option (Right to Buy) | +23,171 | 23,171 | ||
| 2026-03-04 | Lovell Stephanie Director | Sale | −1,193 | $149.62 | $178K | 2,866 |
| 2026-03-04 | Weill David Director | Option exercise | +3,571 | $14.20 | $51K | 15,705 |
| 2026-03-04 | Weill David Director | Sale | −3,571 | $146.82 | $524K | 12,134 |
| 2026-03-04 | Weill David Director | Option exercise · Stock Option (Right to Buy) | −3,571 | 1,429 | ||
| 2026-03-04 | Hernandez Gerardo Chief Financial Officer | Option exercise | +1,324 | $77.12 | $102K | 16,013 |
| 2026-03-04 | Hernandez Gerardo Chief Financial Officer | Sale | −1,324 | $147.21 | $195K | 14,689 |
| 2026-03-04 | Hernandez Gerardo Chief Financial Officer | Option exercise | +5,912 | $69.84 | $413K | 20,601 |
| 2026-03-04 | Hernandez Gerardo Chief Financial Officer | Sale | −5,912 | $147.21 | $870K | 14,689 |
| 2026-03-04 | Hernandez Gerardo Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −1,324 | 3,975 | ||
| 2026-03-04 | Hernandez Gerardo Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −5,912 | 13,010 | ||
| 2026-03-02 | Hernandez Gerardo Chief Financial Officer | Sale | −375 | $139.12 | $52K | 14,689 |
| 2026-03-02 | Ranganath Anil P. See remarks | Sale | −864 | $139.12 | $120K | 13,091 |
| 2026-03-02 | Corcoran Nicholas See remarks | Sale | −2,966 | $139.12 | $413K | 29,831 |
| 2026-02-18 | Cecere Giovanni Chief Commercial Officer | Grant or award | +11,082 | 19,057 | ||
| 2026-02-18 | Cecere Giovanni Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +16,734 | 16,734 | ||
| 2026-01-23 | Corcoran Nicholas See remarks | Shares withheld for taxes | −984 | $135.30 | $133K | 32,797 |
Page 2 of 20 · 390 trades